#United States #New York #Levi Korsinsky #Dentsply Sirona #XRAY

Dentsply Sirona Inc. Class Action Lawsuit: A Call for Investors to Join

Investors in Dentsply Sirona Inc. (NASDAQ: XRAY) are in an uproar following allegations of securities fraud that they claim have led to significant financial losses. A prominent law firm, Levi & Korsinsky, LLP, is spearheading a class action lawsuit to seek justice and potential recovery for affected investors. This lawsuit covers a crucial period between May 6, 2021, and November 6, 2024.

The Allegations Against Dentsply Sirona

The central allegations revolve around a series of misleading statements and actions taken by Dentsply that directly impacted low-income individuals seeking dental care. The lawsuit claims Dentsply targeted vulnerable patients, many of whom lacked access to adequate dental education or services. This strategy allegedly led to many patients with pre-existing dental issues signing up for Byte, Dentsply's direct-to-consumer aligner solution, who were not suitable candidates for such treatment.

The complaints also assert that driven by aggressive sales commissions and expansion goals, Dentsply employees frequently sold products to patients who were contraindicated for treatment. This practice not only put patients at risk but also compromised the patient onboarding process, ultimately allowing unsuitable candidates to receive care.

As if that wasn't alarming enough, reports of injuries among Byte patients reportedly increased during the class period. The lawsuit suggests that Dentsply was well aware of these injuries yet failed to investigate thoroughly or inform the FDA, which is a legal requirement when a company learns of such issues.

Furthermore, the lawsuit emphasizes that Dentsply did not have proper systems in place to report these injuries. Instead, it allegedly chose to maintain a facade of operational success, artificially inflating the goodwill value of its Byte product line. The consequences of these actions led to significant financial repercussions for investors when the truth came to light.

Next Steps for Affected Investors

If you sustained losses as an investor in Dentsply Sirona during the stated time frame, you have until January 27, 2025, to express your interest in being appointed a lead plaintiff. However, it's important to note that you do not need to serve in this role to recover.

Joining this class action poses no out-of-pocket costs or fees to you as a class member. Levi & Korsinsky aims to ensure that affected investors can pursue compensation without the burden of upfront costs, emphasizing that participation is entirely voluntary.

Why Choose Levi & Korsinsky?

With a robust track record spanning over two decades, Levi & Korsinsky has successfully secured hundreds of millions in recoveries for shareholders affected by corporate misconduct. Their experienced team is well-versed in complex securities litigation and dedicated to serving their clients' needs. The firm boasts a significant number of cases ranked in the Top 50 Report by ISS Securities Class Action Services, highlighting their reputation as one of the leading firms in the United States for such lawsuits.

Contact Information

For those interested in joining the lawsuit or requiring further information, you can reach out to Joseph E. Levi or Ed Korsinsky at:

Levi & Korsinsky, LLP
33 Whitehall Street, 17th Floor
New York, NY 10004
Email: contact@zlk.com
Phone: (212) 363-7500

To learn more about the class action and to express your interest in being a part of it, visit Levi & Korsinsky's website. This is a crucial opportunity for investors to seek justice and potentially recover losses due to the alleged mismanagement and misconduct by Dentsply Sirona Inc.